The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Keith B. Glaser

Cancer Research R47J-AP9

Abbott Laboratories

Abbott Park

IL 60064-6121



Name/email consistency: high



  • Cancer Research R47J-AP9, Abbott Laboratories, Abbott Park, IL 60064-6121, USA. 2002 - 2009
  • Division of Hematology/Oncology, Department of Pediatrics, Gwynne Hazen Cherry Memorial Laboratories, David Geffen School of Medicine, USA. 2007


  1. A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Glaser, K.B., Mayer, A.M. Biochem. Pharmacol. (2009) [Pubmed]
  2. ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemia. Shankar, D.B., Li, J., Tapang, P., Owen McCall, J., Pease, L.J., Dai, Y., Wei, R.Q., Albert, D.H., Bouska, J.J., Osterling, D.J., Guo, J., Marcotte, P.A., Johnson, E.F., Soni, N., Hartandi, K., Michaelides, M.R., Davidsen, S.K., Priceman, S.J., Chang, J.C., Rhodes, K., Shah, N., Moore, T.B., Sakamoto, K.M., Glaser, K.B. Blood (2007) [Pubmed]
  3. HDAC inhibitors: clinical update and mechanism-based potential. Glaser, K.B. Biochem. Pharmacol. (2007) [Pubmed]
  4. Differential protein acetylation induced by novel histone deacetylase inhibitors. Glaser, K.B., Li, J., Pease, L.J., Staver, M.J., Marcotte, P.A., Guo, J., Frey, R.R., Garland, R.B., Heyman, H.R., Wada, C.K., Vasudevan, A., Michaelides, M.R., Davidsen, S.K., Curtin, M.L. Biochem. Biophys. Res. Commun. (2004) [Pubmed]
  5. Role of class I and class II histone deacetylases in carcinoma cells using siRNA. Glaser, K.B., Li, J., Staver, M.J., Wei, R.Q., Albert, D.H., Davidsen, S.K. Biochem. Biophys. Res. Commun. (2003) [Pubmed]
  6. Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase. Glaser, K.B., Li, J., Aakre, M.E., Morgan, D.W., Sheppard, G., Stewart, K.D., Pollock, J., Lee, P., O'Connor, C.Z., Anderson, S.N., Mussatto, D.J., Wegner, C.W., Moses, H.L. Mol. Cancer Ther. (2002) [Pubmed]
WikiGenes - Universities